• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人组织型纤溶酶原激活剂与血小板结合的特性研究

Characterization of the binding of human tissue-type plasminogen activator to platelets.

作者信息

Vaughan D E, Mendelsohn M E, Declerck P J, Van Houtte E, Collen D, Loscalzo J

机构信息

Center for Thrombosis and Vascular Research, University of Leuven, Belgium.

出版信息

J Biol Chem. 1989 Sep 25;264(27):15869-74.

PMID:2550424
Abstract

Cell surface binding sites for the constituent proteins of the fibrinolytic system may play a role in the localization and regulation of fibrinolysis. In the present study, specific binding of recombinant human tissue-type plasminogen activator (rt-PA) to human blood platelets was identified and characterized. 125I-labeled rt-PA was found to bind specifically, saturably, and reversibly to the surface of gel-filtered platelets, reaching equilibrium within 5 min at 22 degrees C. Scatchard analysis revealed a single class of binding sites. Unstimulated platelets bound 120,000 +/- 24,000 (mean +/- S.D.) molecules/platelet with an apparent Kd of 340 +/- 25 nM, whereas thrombin-stimulated platelets bound 290,000 +/- 32,000 molecules/platelet with an apparent Kd of 800 +/- 60 nM. Binding of 0.1 microM 125I-rt-PA was greater than 90% reversible by a 50-fold excess of unlabeled rt-PA. Binding was not inhibited by fibrinogen or single chain urokinase-type plasminogen activator, but plasminogen partially competed for binding of 125I-rt-PA to platelets (up to 40% displacement). These findings indicate that the platelet surface possesses a large number of specific, low affinity binding sites for t-PA and provide further evidence for the role of platelets in localization and regulation of fibrinolysis.

摘要

纤溶系统组成蛋白的细胞表面结合位点可能在纤溶作用的定位和调节中发挥作用。在本研究中,鉴定并表征了重组人组织型纤溶酶原激活剂(rt-PA)与人血小板的特异性结合。发现125I标记的rt-PA能特异性、饱和性和可逆性地结合到凝胶过滤血小板表面,在22℃下5分钟内达到平衡。Scatchard分析显示存在一类结合位点。未刺激的血小板以340±25 nM的表观解离常数结合120,000±24,000(平均值±标准差)个分子/血小板,而凝血酶刺激的血小板以800±60 nM的表观解离常数结合290,000±32,000个分子/血小板。0.1μM的125I-rt-PA的结合在加入50倍过量的未标记rt-PA后有超过90%的可逆性。纤维蛋白原或单链尿激酶型纤溶酶原激活剂不抑制结合,但纤溶酶原部分竞争125I-rt-PA与血小板的结合(高达40%的置换)。这些发现表明血小板表面具有大量针对t-PA的特异性低亲和力结合位点,并为血小板在纤溶作用的定位和调节中的作用提供了进一步证据。

相似文献

1
Characterization of the binding of human tissue-type plasminogen activator to platelets.人组织型纤溶酶原激活剂与血小板结合的特性研究
J Biol Chem. 1989 Sep 25;264(27):15869-74.
2
Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes.血小板膜中一种新型尿激酶型纤溶酶原激活剂结合蛋白的证据。
Blood. 1996 Apr 1;87(7):2775-81.
3
Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.使纤维蛋白与整合素受体解偶联可加速血小板 - 纤维蛋白界面处的纤维蛋白溶解。
Blood. 1994 Feb 15;83(4):982-93.
4
Binding and activation of plasminogen on the platelet surface.纤溶酶原在血小板表面的结合与激活。
J Biol Chem. 1985 Apr 10;260(7):4303-11.
5
Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.血管平滑肌细胞上尿激酶型纤溶酶原激活物受体的调控受凝血酶和其他促细胞分裂剂的控制。
Arterioscler Thromb. 1992 Oct;12(10):1161-70. doi: 10.1161/01.atv.12.10.1161.
6
Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation.
Biochemistry. 1993 May 4;32(17):4628-33. doi: 10.1021/bi00068a021.
7
Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.通过化学交联鉴定大鼠肝癌细胞上组织型纤溶酶原激活物(t-PA)结合蛋白并对其进行部分特性分析。一种1型纤溶酶原激活物抑制剂非依赖性t-PA受体。
J Biol Chem. 1992 Aug 5;267(22):15595-602.
8
Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.凝血酶可降低培养的内皮细胞中的尿激酶受体及表面定位的纤维蛋白溶解作用。
Arterioscler Thromb Vasc Biol. 1995 Mar;15(3):410-9. doi: 10.1161/01.atv.15.3.410.
9
Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.组织型纤溶酶原激活剂和尿激酶的人内皮细胞膜结合位点的鉴定与特性分析
J Biol Chem. 1990 Feb 15;265(5):2908-16.
10
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.单链尿激酶型纤溶酶原激活剂与人内皮细胞的相互作用。
J Biol Chem. 1990 Feb 15;265(5):2865-72.

引用本文的文献

1
Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications.纤溶酶原激活系统在血小板病理生理学中的作用:转化应用的新观点。
Int J Mol Sci. 2022 May 28;23(11):6065. doi: 10.3390/ijms23116065.
2
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets.激活的凝血酶激活的纤溶抑制物(TAFIa)可减弱在凝血酶激活的血小板上纤维蛋白依赖性纤溶酶原的生成。
J Thromb Haemost. 2020 Sep;18(9):2364-2376. doi: 10.1111/jth.14950.
3
Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets.
纤维蛋白凝块表面的纤溶酶原可防止白细胞和血小板黏附。
J Thromb Haemost. 2010 Apr;8(4):799-807. doi: 10.1111/j.1538-7836.2010.03778.x. Epub 2009 Jan 22.
4
Platelet activation in acute myocardial infarction and the rationale for combination therapy.急性心肌梗死中的血小板活化及联合治疗的理论依据
Curr Cardiol Rep. 2000 Sep;2(5):378-85. doi: 10.1007/s11886-000-0050-1.